rethinkPeptides Search
Menu
Research citation

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.

Arthritis and rheumatism, 58(12), 3873-83

Citation

Muller, Sylviane; Monneaux, Fanny; Schall, Nicolas; Rashkov, Rasho K; Oparanov, Boycho A; Wiesel, Philippe; Geiger, Jean-Marie; Zimmer, Robert. (2008). Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.. Arthritis and rheumatism, 58(12), 3873-83. https://doi.org/10.1002/art.24027